KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Total Non-Current Liabilities (2017 - 2025)

Historic Total Non-Current Liabilities for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $2.5 billion.

  • Moderna's Total Non-Current Liabilities fell 2988.89% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 2988.89%. This contributed to the annual value of $3.0 billion for FY2024, which is 3109.36% down from last year.
  • According to the latest figures from Q3 2025, Moderna's Total Non-Current Liabilities is $2.5 billion, which was down 2988.89% from $2.3 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Total Non-Current Liabilities ranged from a high of $10.8 billion in Q3 2021 and a low of $2.3 billion during Q2 2025
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $5.1 billion (2023), whereas its average is $6.0 billion.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 198123.74% in 2021, then tumbled by 5117.3% in 2023.
  • Quarter analysis of 5 years shows Moderna's Total Non-Current Liabilities stood at $10.4 billion in 2021, then crashed by 36.83% to $6.6 billion in 2022, then crashed by 34.61% to $4.3 billion in 2023, then crashed by 31.09% to $3.0 billion in 2024, then dropped by 15.13% to $2.5 billion in 2025.
  • Its Total Non-Current Liabilities stands at $2.5 billion for Q3 2025, versus $2.3 billion for Q2 2025 and $2.4 billion for Q1 2025.